Abacavir and Peripheral neuropathy - a phase IV clinical study of FDA data
Summary:
Peripheral neuropathy is reported as a side effect among people who take Abacavir (abacavir sulfate), especially for people who are male, 50-59 old, also take Stavudine,.
The phase IV clinical study analyzes which people have Peripheral neuropathy when taking Abacavir. It is created by eHealthMe based on reports of 8,281 people who have side effects when taking Abacavir from the FDA, and is updated regularly.
What is Abacavir?
Abacavir has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 8,306 Abacavir users. Check the latest studies of Abacavir.
What is Peripheral neuropathy?
Peripheral neuropathy (damage to nerves of the peripheral nervous system) is found to be associated with 503 drugs and 879 conditions by eHealthMe. Check the latest studies of Peripheral neuropathy.
8,281 people reported to have side effects when taking Abacavir.
Among them, 23 people (0.28%) have Peripheral neuropathy.

Among these 23 people:
What is the gender of people who have Peripheral neuropathy when taking Abacavir? *
- female: 4.55 %
- male: 95.45 %
What is the age of people who have Peripheral neuropathy when taking Abacavir? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 4.35 %
- 20-29: 4.35 %
- 30-39: 21.74 %
- 40-49: 21.74 %
- 50-59: 30.43 %
- 60+: 17.39 %
What are other drugs people take besides Abacavir? *
- Stavudine: 9 people, 39.13%
- Efavirenz: 8 people, 34.78%
- Epivir: 7 people, 30.43%
- Didanosine: 5 people, 21.74%
- Lamivudine: 5 people, 21.74%
- Crixivan: 5 people, 21.74%
- Nevirapine: 5 people, 21.74%
- Kaletra: 4 people, 17.39%
- Combivir: 4 people, 17.39%
- Zidovudine: 3 people, 13.04%
What are other side effects people have besides Peripheral neuropathy? *
- Myopathy (a muscular disease in which the muscle fibres do not function): 4 people, 17.39%
- Fever: 4 people, 17.39%
- Lactic Acidosis (low ph in body tissues): 3 people, 13.04%
- Muscle Aches (muscle pain): 3 people, 13.04%
- Weight Decreased: 2 people, 8.70%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 8.70%
- Blood Creatine Phosphokinase Increased: 2 people, 8.70%
- Heart Attack: 2 people, 8.70%
- Acute Kidney Failure: 2 people, 8.70%
- Urination - Excessive At Night: 2 people, 8.70%
* Approximation only. Some reports may have incomplete information.
Do you take Abacavir and have Peripheral neuropathy?
- Check whether Peripheral neuropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Abacavir:
- Abacavir (8,306 reports)
Peripheral neuropathy treatments and more:
- Peripheral neuropathy (7,873 reports)
How severe was Peripheral neuropathy and when was it recovered:
Expand to all the drugs that have ingredients of abacavir sulfate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abacavir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Peripheral neuropathy:
- Peripheral neuropathy (503 drugs)
Browse all the conditions that are associated with Peripheral neuropathy:
- Peripheral neuropathy (879 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on abacavir sulfate (the active ingredients of Abacavir) and Abacavir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Metformin cause Joint Instability? - 10 seconds ago
- Heart Attack and drugs of ingredients of deferoxamine mesylate - 12 seconds ago
- Could Amitriptyline Hydrochloride cause Spinal Stenosis? - 20 seconds ago
- Lo Loestrin Fe vs. Nuvaring, side effect and effectiveness comparison - 27 seconds ago
- Nizoral and Pain Relief for Men aged 60+ - 38 seconds ago
- Nizoral and Hypnosis And Pain for Men aged 60+ - 38 seconds ago
- Nizoral and Alternative Medicine - Pain Relief for Men aged 60+ - 39 seconds ago
- Drug interactions of Activase and Insulin - 39 seconds ago
- Nizoral and Pain for Men aged 60+ - 39 seconds ago
- Could Hyzaar cause Hypophosphataemia? - 51 seconds ago